Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Clinical trial NCT02652130 · COMPLETED
Trial details
- NCT number
- NCT02652130
- Sponsor
- Mesoblast, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-28
- Primary completion
- 2018-06-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.